|
2025-03-05 |
2025-03-03 |
V
Vente
|
Colvin Richard A
Chief Medical Officer
Dirigeant
|
584
-7.1%
3,92
2 289 USD
|
584
-7.1%
|
3,92
|
2 289 USD
|
|
|
2025-03-05 |
2025-03-03 |
V
Vente
|
Klima Thomas J
See Remarks
Dirigeant
|
500
-6.0%
3,92
1 960 USD
|
500
-6.0%
|
3,92
|
1 960 USD
|
|
|
2025-03-05 |
2025-03-03 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
921
-4.8%
3,92
3 610 USD
|
921
-4.8%
|
3,92
|
3 610 USD
|
|
|
2025-02-05 |
2025-02-03 |
V
Vente
|
Klima Thomas J
See Remarks
Dirigeant
|
122
-1.4%
7,39
902 USD
|
122
-1.4%
|
7,39
|
902 USD
|
|
|
2025-02-05 |
2025-02-03 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
86
-0.5%
7,39
636 USD
|
86
-0.5%
|
7,39
|
636 USD
|
|
|
2025-02-05 |
2025-02-03 |
V
Vente
|
Vittiglio Joseph
Chief Business & Legal Officer
Dirigeant
|
238
-5.0%
7,39
1 759 USD
|
238
-5.0%
|
7,39
|
1 759 USD
|
|
|
2025-02-05 |
2025-02-03 |
V
Vente
|
Colvin Richard A
Chief Medical Officer
Dirigeant
|
64
-0.8%
7,39
473 USD
|
64
-0.8%
|
7,39
|
473 USD
|
|
|
2025-01-08 |
2025-01-06 |
V
Vente
|
Colvin Richard A
Chief Medical Officer
Dirigeant
|
19
-0.2%
9,24
176 USD
|
19
-0.2%
|
9,24
|
176 USD
|
|
|
2025-01-08 |
2025-01-06 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
140
-0.7%
9,24
1 294 USD
|
140
-0.7%
|
9,24
|
1 294 USD
|
|
|
2024-12-12 |
2024-12-10 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
971
-0.3%
0,42
405 USD
|
971
-0.3%
|
0,42
|
405 USD
|
|
|
2024-12-12 |
2024-12-10 |
V
Vente
|
Colvin Richard A
Chief Medical Officer
Dirigeant
|
2 824
-1.7%
0,42
1 178 USD
|
2 824
-1.7%
|
0,42
|
1 178 USD
|
|
|
2024-10-02 |
2024-09-30 |
V
Vente
|
Klima Thomas J
See Remarks
Dirigeant
|
1 006
-0.6%
0,53
529 USD
|
1 006
-0.6%
|
0,53
|
529 USD
|
|
|
2024-10-02 |
2024-09-30 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
34 780
-8.5%
0,53
18 270 USD
|
34 780
-8.5%
|
0,53
|
18 270 USD
|
|
|
2024-06-04 |
2024-06-03 |
V
Vente
|
Klima Thomas J
See Remarks
Dirigeant
|
3 834
-3.1%
0,97
3 726 USD
|
3 834
-3.1%
|
0,97
|
3 726 USD
|
|
|
2024-03-05 |
2024-03-04 |
V
Vente
|
Klima Thomas J
See Remarks
Dirigeant
|
4 573
-3.5%
1,53
6 986 USD
|
4 573
-3.5%
|
1,53
|
6 986 USD
|
|
|
2024-03-05 |
2024-03-04 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
6 095
-2.1%
1,53
9 311 USD
|
6 095
-2.1%
|
1,53
|
9 311 USD
|
|
|
2024-03-05 |
2024-03-01 |
V
Vente
|
Colvin Richard A
Chief Medical Officer
Dirigeant
|
6 770
-5.4%
1,53
10 342 USD
|
6 770
-5.4%
|
1,53
|
10 342 USD
|
|
|
2024-02-06 |
2024-02-05 |
V
Vente
|
Klima Thomas J
See Remarks
Dirigeant
|
2 714
-2.1%
0,90
2 449 USD
|
2 714
-2.1%
|
0,90
|
2 449 USD
|
|
|
2024-02-06 |
2024-02-05 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
1 879
-0.7%
0,90
1 696 USD
|
1 879
-0.7%
|
0,90
|
1 696 USD
|
|
|
2024-02-06 |
2024-02-05 |
V
Vente
|
Vittiglio Joseph
Chief Business & Legal Officer
Dirigeant
|
5 217
-10.4%
0,90
4 708 USD
|
5 217
-10.4%
|
0,90
|
4 708 USD
|
|
|
2024-01-09 |
2024-01-05 |
V
Vente
|
Colvin Richard A
Chief Medical Officer
Dirigeant
|
597
-0.5%
1,42
845 USD
|
597
-0.5%
|
1,42
|
845 USD
|
|
|
2024-01-09 |
2024-01-05 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
3 162
-1.1%
1,43
4 520 USD
|
3 162
-1.1%
|
1,43
|
4 520 USD
|
|
|
2023-12-08 |
2023-12-06 |
V
Vente
|
Krawtschuk Christopher
Chief Financial Officer
Dirigeant
|
4 526
-9.1%
4,52
20 437 USD
|
4 526
-9.1%
|
4,52
|
20 437 USD
|
|
|
2023-11-03 |
2023-11-03 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
807
-0.3%
3,17
2 555 USD
|
807
-0.3%
|
3,17
|
2 555 USD
|
|
|
2023-11-03 |
2023-11-02 |
V
Vente
|
Colvin Richard A
Chief Medical Officer
Dirigeant
|
2 343
-1.8%
2,98
6 975 USD
|
2 343
-1.8%
|
2,98
|
6 975 USD
|
|
|
2023-09-06 |
2023-09-05 |
V
Vente
|
Klima Thomas J
See Remarks
Dirigeant
|
922
-0.7%
3,79
3 493 USD
|
922
-0.7%
|
3,79
|
3 493 USD
|
|
|
2023-08-10 |
2023-08-10 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
16 929
-5.5%
3,54
59 956 USD
|
16 929
-5.5%
|
3,54
|
59 956 USD
|
|
|
2023-06-06 |
2023-06-02 |
V
Vente
|
Klima Thomas J
See Remarks
Dirigeant
|
4 130
-3.0%
3,50
14 451 USD
|
4 130
-3.0%
|
3,50
|
14 451 USD
|
|
|
2023-01-13 |
2023-01-11 |
V
Vente
|
Leschly Nick
Administrateur non-exécutif
|
4 290
-1.5%
7,80
33 480 USD
|
4 290
-1.5%
|
7,80
|
33 480 USD
|
|
|
2023-01-13 |
2023-01-11 |
V
Vente
|
Colvin Richard A
Chief Medical Officer
Dirigeant
|
557
-0.7%
7,80
4 347 USD
|
557
-0.7%
|
7,80
|
4 347 USD
|
|
|
2023-01-13 |
2023-01-11 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
3 178
-1.3%
7,80
24 802 USD
|
3 178
-1.3%
|
7,80
|
24 802 USD
|
|
|
2022-11-08 |
2022-11-04 |
V
Vente
|
Colvin Richard A
Chief Medical Officer
Dirigeant
|
218
-0.3%
6,41
1 398 USD
|
218
-0.3%
|
6,41
|
1 398 USD
|
|
|
2022-11-08 |
2022-11-04 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
1 263
-0.5%
6,41
8 101 USD
|
1 263
-0.5%
|
6,41
|
8 101 USD
|
|
|
2023-03-09 |
2022-10-17 |
V
Vente
|
Leiderman Elisabeth
Administrateur non-exécutif
|
1 004
-8.1%
6,46
6 490 USD
|
1 004
-8.1%
|
6,46
|
6 490 USD
|
|
|
2022-08-23 |
2022-08-19 |
V
Vente
|
Cole Jason
Chief Strategy & Financial Off
Dirigeant
|
14 194
-7.0%
5,53
78 473 USD
|
14 194
-7.0%
|
5,53
|
78 473 USD
|
|
|
2022-08-08 |
2022-08-04 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
21 805
-8.1%
4,39
95 754 USD
|
21 805
-8.1%
|
4,39
|
95 754 USD
|
|
|
2022-08-08 |
2022-08-04 |
V
Vente
|
Cole Jason
Chief Strategy & Financial Off
Dirigeant
|
7 448
-3.5%
4,39
32 707 USD
|
7 448
-3.5%
|
4,39
|
32 707 USD
|
|
|
2022-07-14 |
2022-07-12 |
V
Vente
|
Eggimann Anne-Virginie
Chief Regulatory Officer
Dirigeant
|
1 358
-3.1%
4,95
6 722 USD
|
1 358
-3.1%
|
4,95
|
6 722 USD
|
|
|
2022-06-07 |
2022-06-03 |
V
Vente
|
Klima Thomas J
Chief Commercial Officer
Dirigeant
|
3 753
-5.0%
3,07
11 535 USD
|
3 753
-5.0%
|
3,07
|
11 535 USD
|
|
|
2022-01-12 |
2022-01-11 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
4 683
-1.9%
9,64
45 156 USD
|
4 683
-1.9%
|
9,64
|
45 156 USD
|
|
|
2022-01-12 |
2022-01-11 |
V
Vente
|
Whitten Jessica
Chief Accounting Officer
Dirigeant
|
279
-0.6%
9,64
2 690 USD
|
279
-0.6%
|
9,64
|
2 690 USD
|
|
|
2022-01-12 |
2022-01-11 |
V
Vente
|
Cole Jason
Chief Operating and
Dirigeant
|
3 387
-1.8%
9,64
32 659 USD
|
3 387
-1.8%
|
9,64
|
32 659 USD
|
|
|
2022-01-12 |
2022-01-11 |
V
Vente
|
Leschly Nick
Administrateur non-exécutif
|
5 068
-1.8%
9,64
48 869 USD
|
5 068
-1.8%
|
9,64
|
48 869 USD
|
|
|
2022-01-12 |
2022-01-10 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
2 190
-0.9%
9,40
20 591 USD
|
2 190
-0.9%
|
9,40
|
20 591 USD
|
|
|
2022-01-12 |
2022-01-10 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
852
-0.3%
9,24
7 876 USD
|
852
-0.3%
|
9,24
|
7 876 USD
|
|
|
2022-01-12 |
2022-01-10 |
V
Vente
|
Whitten Jessica
Chief Accounting Officer
Dirigeant
|
130
-0.3%
9,40
1 222 USD
|
130
-0.3%
|
9,40
|
1 222 USD
|
|
|
2022-01-12 |
2022-01-10 |
V
Vente
|
Cole Jason
Chief Operating and
Dirigeant
|
1 584
-0.8%
9,40
14 893 USD
|
1 584
-0.8%
|
9,40
|
14 893 USD
|
|
|
2022-01-12 |
2022-01-10 |
V
Vente
|
Leschly Nick
Administrateur non-exécutif
|
2 369
-0.8%
9,40
22 274 USD
|
2 369
-0.8%
|
9,40
|
22 274 USD
|
|
|
2022-01-07 |
2022-01-05 |
V
Vente
|
Whitten Jessica
Chief Accounting Officer
Dirigeant
|
2 984
-5.7%
10,44
31 143 USD
|
2 984
-5.7%
|
10,44
|
31 143 USD
|
|
|
2021-12-09 |
2021-12-07 |
V
Vente
|
Obenshain Andrew
President and CEO
Administrateur exécutif
|
832
-0.3%
10,18
8 469 USD
|
832
-0.3%
|
10,18
|
8 469 USD
|
|
|
2021-06-08 |
2021-06-04 |
V
Vente
|
Obenshain Andrew
President of SGD
Dirigeant
|
511
-1.3%
30,75
15 715 USD
|
511
-1.3%
|
30,75
|
15 715 USD
|
|
|
2021-05-05 |
2021-05-03 |
V
Vente
|
Leschly Nick
President and CEO
Administrateur exécutif
|
444
-0.1%
30,15
13 387 USD
|
444
-0.1%
|
30,15
|
13 387 USD
|
|
|
2021-05-05 |
2021-05-03 |
V
Vente
|
Obenshain Andrew
President of SGD
Dirigeant
|
29
-0.1%
30,15
874 USD
|
29
-0.1%
|
30,15
|
874 USD
|
|
|
2021-04-07 |
2021-04-05 |
V
Vente
|
Obenshain Andrew
President of SGD
Dirigeant
|
29
-0.1%
30,21
876 USD
|
29
-0.1%
|
30,21
|
876 USD
|
|
|
2021-04-07 |
2021-04-05 |
V
Vente
|
Cole Jason
Chief Operating and
Dirigeant
|
37
-0.1%
30,21
1 118 USD
|
37
-0.1%
|
30,21
|
1 118 USD
|
|
|
2021-04-07 |
2021-04-05 |
V
Vente
|
Gregory Philip D
Chief Scientific Officer
Dirigeant
|
39
-0.1%
30,21
1 178 USD
|
39
-0.1%
|
30,21
|
1 178 USD
|
|
|
2021-03-04 |
2021-03-02 |
V
Vente
|
Davidson David
Chief Medical Officer
Dirigeant
|
42
-0.1%
29,58
1 242 USD
|
42
-0.1%
|
29,58
|
1 242 USD
|
|
|
2021-03-04 |
2021-03-02 |
V
Vente
|
Cole Jason
Chief Operating and
Dirigeant
|
38
-0.1%
29,58
1 124 USD
|
38
-0.1%
|
29,58
|
1 124 USD
|
|
|
2021-03-04 |
2021-03-02 |
V
Vente
|
Gregory Philip D
Chief Scientific Officer
Dirigeant
|
39
-0.1%
29,58
1 154 USD
|
39
-0.1%
|
29,58
|
1 154 USD
|
|
|
2021-03-04 |
2021-03-02 |
V
Vente
|
Leschly Nick
President and CEO
Administrateur exécutif
|
444
-0.4%
29,58
13 134 USD
|
444
-0.4%
|
29,58
|
13 134 USD
|
|
|
2021-03-04 |
2021-03-02 |
V
Vente
|
Obenshain Andrew
President of SGD
Dirigeant
|
34
-0.1%
29,58
1 006 USD
|
34
-0.1%
|
29,58
|
1 006 USD
|
|
|
2021-02-18 |
2021-02-17 |
V
Vente
|
Gregory Philip D
Chief Scientific Officer
Dirigeant
|
664
-1.4%
28,16
18 699 USD
|
664
-1.4%
|
28,16
|
18 699 USD
|
|
|
2021-02-18 |
2021-02-17 |
V
Vente
|
Obenshain Andrew
President of SGD
Dirigeant
|
749
-1.8%
28,16
21 093 USD
|
749
-1.8%
|
28,16
|
21 093 USD
|
|
|
2021-02-18 |
2021-02-17 |
V
Vente
|
Cole Jason
Chief Operating and
Dirigeant
|
665
-1.4%
28,16
18 727 USD
|
665
-1.4%
|
28,16
|
18 727 USD
|
|
|
2021-02-18 |
2021-02-17 |
V
Vente
|
Baird William D III
Chief Financial Officer
Dirigeant
|
693
-1.9%
28,16
19 516 USD
|
693
-1.9%
|
28,16
|
19 516 USD
|
|
|
2021-02-18 |
2021-02-17 |
V
Vente
|
Davidson David
Chief Medical Officer
Dirigeant
|
698
-1.4%
28,16
19 657 USD
|
698
-1.4%
|
28,16
|
19 657 USD
|
|
|
2021-02-18 |
2021-02-17 |
V
Vente
|
Burnett Katy
Principal Accounting Officer
Dirigeant
|
518
-11.2%
28,16
14 588 USD
|
518
-11.2%
|
28,16
|
14 588 USD
|
|
|
2021-02-17 |
2021-02-12 |
V
Vente
|
Baird William D III
Chief Financial Officer
Dirigeant
|
1 216
-5.3%
45,52
55 352 USD
|
1 216
-5.3%
|
45,52
|
55 352 USD
|
|
|
2021-02-04 |
2021-02-02 |
V
Vente
|
Obenshain Andrew
President of SGD
Dirigeant
|
34
-0.1%
45,93
1 561 USD
|
34
-0.1%
|
45,93
|
1 561 USD
|
|
|
2021-02-04 |
2021-02-02 |
V
Vente
|
Gregory Philip D
Chief Scientific Officer
Dirigeant
|
59
-0.2%
45,93
2 710 USD
|
59
-0.2%
|
45,93
|
2 710 USD
|
|
|
2021-02-04 |
2021-02-02 |
V
Vente
|
Leschly Nick
President and CEO
Administrateur exécutif
|
594
-0.7%
45,93
27 280 USD
|
594
-0.7%
|
45,93
|
27 280 USD
|
|
|
2021-02-04 |
2021-02-02 |
V
Vente
|
Cole Jason
Chief Operating and
Dirigeant
|
38
-0.1%
45,93
1 745 USD
|
38
-0.1%
|
45,93
|
1 745 USD
|
|
|
2021-02-04 |
2021-02-02 |
V
Vente
|
Davidson David
Chief Medical Officer
Dirigeant
|
63
-0.2%
45,93
2 893 USD
|
63
-0.2%
|
45,93
|
2 893 USD
|
|
|
2021-01-08 |
2021-01-06 |
V
Vente
|
Gregory Philip D
Chief Scientific Officer
Dirigeant
|
1 152
-3.4%
45,46
52 374 USD
|
1 152
-3.4%
|
45,46
|
52 374 USD
|
|
|
2021-01-08 |
2021-01-06 |
V
Vente
|
Gregory Philip D
Chief Scientific Officer
Dirigeant
|
1 602
-4.5%
44,76
71 703 USD
|
1 602
-4.5%
|
44,76
|
71 703 USD
|
|
